Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer.

Wassersug RJ, Lyons A, Duncan D, Dowsett GW, Pitts M.

Urology. 2013 Sep;82(3):565-71. doi: 10.1016/j.urology.2013.04.022. Epub 2013 Jun 14.

PMID:
23768520
[PubMed - indexed for MEDLINE]
2.

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.

J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67.

PMID:
15367568
[PubMed - indexed for MEDLINE]
Free Article
3.

Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.

Hedgepeth RC, Labo J, Zhang L, Wood DP Jr.

J Urol. 2009 Jul;182(1):221-7; discussion 227-8. doi: 10.1016/j.juro.2009.02.155. Epub 2009 May 17.

PMID:
19450842
[PubMed - indexed for MEDLINE]
4.

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC.

J Natl Cancer Inst. 2000 Oct 4;92(19):1582-92.

PMID:
11018094
[PubMed - indexed for MEDLINE]
Free Article
5.

Defining sexual outcomes after treatment for localized prostate carcinoma.

Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA.

Cancer. 2002 Oct 15;95(8):1773-85.

PMID:
12365027
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Effect of treatment on quality of life among men with clinically localized prostate cancer.

Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB.

Med Care. 2001 Mar;39(3):243-53.

PMID:
11242319
[PubMed - indexed for MEDLINE]
8.
9.

Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy.

Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR, Richie JP, Kantoff PW.

J Natl Cancer Inst. 1997 Aug 6;89(15):1117-23.

PMID:
9262249
[PubMed - indexed for MEDLINE]
Free Article
10.

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS.

J Natl Cancer Inst. 2009 Jun 16;101(12):888-92. doi: 10.1093/jnci/djp114. Epub 2009 Jun 9.

PMID:
19509365
[PubMed - indexed for MEDLINE]
Free Article
11.

Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.

Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schröder FH.

J Clin Oncol. 2001 Mar 15;19(6):1619-28.

PMID:
11250990
[PubMed - indexed for MEDLINE]
12.

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

Lilleby W, Fosså SD, Waehre HR, Olsen DR.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43.

PMID:
10098428
[PubMed - indexed for MEDLINE]
13.

Complications from treatment for prostate carcinoma among men in the Detroit area.

Schwartz K, Bunner S, Bearer R, Severson RK.

Cancer. 2002 Jul 1;95(1):82-9.

PMID:
12115320
[PubMed - indexed for MEDLINE]
Free Article
14.

Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.

Bradley EB, Bissonette EA, Theodorescu D.

BJU Int. 2004 Nov;94(7):1003-9.

PMID:
15541117
[PubMed - indexed for MEDLINE]
15.

Flexibility in Men's Sexual Practices in Response to Iatrogenic Erectile Dysfunction after Prostate Cancer Treatment.

Dowsett GW, Lyons A, Duncan D, Wassersug RJ.

Sex Med. 2014 Aug;2(3):115-20. doi: 10.1002/sm2.32.

PMID:
25356308
[PubMed]
Free PMC Article
16.

Erectile and ejaculatory problems in gay and heterosexual men.

Bancroft J, Carnes L, Janssen E, Goodrich D, Long JS.

Arch Sex Behav. 2005 Jun;34(3):285-97.

PMID:
15971011
[PubMed - indexed for MEDLINE]
17.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K.

Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7. Review.

PMID:
21984740
[PubMed - indexed for MEDLINE]
18.

Erectile dysfunction and urinary incontinence after prostate cancer treatment.

Mirza M, Griebling TL, Kazer MW.

Semin Oncol Nurs. 2011 Nov;27(4):278-89. doi: 10.1016/j.soncn.2011.07.006. Review.

PMID:
22018407
[PubMed - indexed for MEDLINE]
19.

Five-year downstream outcomes following prostate-specific antigen screening in older men.

Walter LC, Fung KZ, Kirby KA, Shi Y, Espaldon R, O'Brien S, Freedland SJ, Powell AA, Hoffman RM.

JAMA Intern Med. 2013 May 27;173(10):866-73. doi: 10.1001/jamainternmed.2013.323.

PMID:
23588999
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Symptom indexes to assess outcomes of treatment for early prostate cancer.

Clark JA, Talcott JA.

Med Care. 2001 Oct;39(10):1118-30.

PMID:
11567174
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk